Duchenne muscular dystrophy (DMD) is a rapidly progressive X-linked recessive disease, with symptom onset before age 6 years in boys. It is the most common form of muscular dystrophy in childhood, occurring among 1 in 3600 to 9300 male newborns worldwide.
1 The disease is caused by variants in the
DMD gene, which codes for the dystrophin protein.
2 The lack of dystrophin results in membrane fragility, necrosis, inflammation, and progressive muscle atrophy.
3 Aberrant intracellular signaling cascades also contribute to DMD pathophysiology. Upregulated inflammatory gene expression and activated immune cell infiltrates, at least partially mediated by nuclear factor κ light chain enhancer of activated B cells (NF-κB) activation, are evident during early disease stages and play a significant role in disease progression.
3-5 NF-κB regulates expression of numerous inflammatory genes in immune cells and muscle fibers,
6-9 and the infiltration and activation of these cells can trigger muscle cell death.
10,11